Back to School: How biopharma can reboot drug development. Access exclusive analysis here
Genzyme Biosurgery (GZBX) shareholders Rory Riggs and John Lewis filed suit in the U.S. District Court for the Southern District of
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury